The ABCs of systemic healthcare reform - Cerner Corporation
The ABCs of systemic healthcare reform - Cerner Corporation
The ABCs of systemic healthcare reform - Cerner Corporation
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
amounts that include the amounts attributable to both the parent and the noncontrolling interest. <strong>The</strong> Company is currently<br />
assessing the impact <strong>of</strong> adoption <strong>of</strong> SFAS 160 on its results <strong>of</strong> operations and its financial position, both <strong>of</strong> which are expected<br />
to be immaterial, and was required to adopt SFAS 160 as <strong>of</strong> the first day <strong>of</strong> the 2009 fiscal year.<br />
In March 2008, the FASB issued Statement <strong>of</strong> Accounting Standards No. 161, “Disclosures about Derivative Instruments and<br />
Hedging Activities – an amendment <strong>of</strong> FASB Statement No. 133.” SFAS 161 requires enhanced disclosures about the uses <strong>of</strong><br />
derivative instruments and hedging activities, how these activities are accounted for, and their respective impact on an entity’s<br />
financial position, financial performance, and cash flows. <strong>The</strong> Company is currently assessing the impact <strong>of</strong> adoption <strong>of</strong> SFAS<br />
161 on its results <strong>of</strong> operations and its financial position, which is expected to be immaterial, and was required to adopt SFAS<br />
161 as <strong>of</strong> the first day <strong>of</strong> the 2009 fiscal year.<br />
(2) Business Acquisitions<br />
During the three years ended January 3, 2009, the Company completed three acquisitions, which were accounted for under the<br />
purchase method <strong>of</strong> accounting. <strong>The</strong> results <strong>of</strong> each acquisition are included in the Company’s consolidated statements <strong>of</strong><br />
operations from the date <strong>of</strong> each acquisition. Below is a description <strong>of</strong> the acquisitions.<br />
On August 1, 2008, the Company completed the purchase <strong>of</strong> LingoLogix, Inc. (“LingoLogix”), for $4,000,000. LingoLogix was a<br />
provider <strong>of</strong> s<strong>of</strong>tware used for computer automated coding technology. <strong>The</strong> acquisition <strong>of</strong> LingoLogix has enhanced the<br />
Company’s revenue cycling <strong>of</strong>ferings as the solutions can be used in both inpatient and outpatient environments to improve<br />
physician workflow and drive more accurate and efficient reimbursement through automated coding. <strong>The</strong> operating results <strong>of</strong><br />
LingoLogix were combined with those <strong>of</strong> the Company subsequent to the purchase date <strong>of</strong> August 1, 2008. <strong>The</strong> allocation <strong>of</strong><br />
the purchase price to the estimated fair values <strong>of</strong> the identified tangible and intangible assets acquired and liabilities assumed<br />
resulted in goodwill <strong>of</strong> $1,253,000 and $4,053,000 in intangible assets. <strong>The</strong> intangible assets are being amortized over 5<br />
years. <strong>The</strong> goodwill was allocated to the reporting unit. Pro-forma results <strong>of</strong> operations have not been presented because the<br />
effect <strong>of</strong> this acquisition was not material to the Company.<br />
On February 22, 2007, the Company completed the purchase <strong>of</strong> assets <strong>of</strong> Etreby Computer Company, Inc. (“Etreby”), for<br />
$25,120,000, which was reduced by $1,588,000 for a working capital adjustment in the second quarter <strong>of</strong> 2007. Etreby was a<br />
s<strong>of</strong>tware provider <strong>of</strong> retail pharmacy management systems. <strong>The</strong> acquisition <strong>of</strong> Etreby’s assets has expanded the Company’s<br />
pharmacy systems portfolio. <strong>The</strong> operating results <strong>of</strong> Etreby were combined with those <strong>of</strong> the Company subsequent to the<br />
purchase date <strong>of</strong> February 22, 2007. <strong>The</strong> allocation <strong>of</strong> the purchase price to the estimated fair values <strong>of</strong> the identified tangible<br />
and intangible assets acquired and liabilities assumed resulted in goodwill <strong>of</strong> $12,676,000 and $10,181,000 in intangible<br />
assets. <strong>The</strong> intangible assets are being amortized over five years. <strong>The</strong> goodwill was allocated to the reporting unit and is<br />
expected to be deductible for tax purposes. Pro-forma results <strong>of</strong> operations have not been presented because the effect <strong>of</strong> this<br />
acquisition was not material to the Company.<br />
On July 5, 2006, the Company completed the purchase <strong>of</strong> Galt Associates, Inc., now known as <strong>Cerner</strong> Galt, Inc. (“Galt”) for<br />
$13,766,000, net <strong>of</strong> cash acquired. Galt is a provider <strong>of</strong> safety and risk management solutions for pharmaceutical, medical<br />
device and biotechnology companies. <strong>The</strong> acquisition <strong>of</strong> Galt has enhanced the Company’s LifeSciences portfolio by adding<br />
solutions and services that use medical event data to monitor and manage the safety and effectiveness <strong>of</strong> various therapies.<br />
<strong>The</strong> allocation <strong>of</strong> the purchase price to the estimated fair values <strong>of</strong> the identified tangible and intangible assets acquired and<br />
liabilities assumed, resulted in goodwill <strong>of</strong> $9,298,000 and $4,266,000 in intangible assets. <strong>The</strong> intangible assets are being<br />
amortized over periods between two and five years. <strong>The</strong> goodwill was allocated to the reporting unit.<br />
All <strong>of</strong> the goodwill for the above acquisitions has been allocated to the Company’s Domestic operating segment.<br />
69